The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo.

Autor: Grimes, Martha M.1 (AUTHOR) MGrimes@salud.unm.edu, Kenney, S. Ray1,2 (AUTHOR), Dominguez, Dayna R.1 (AUTHOR), Brayer, Kathryn J.3,4 (AUTHOR), Guo, Yuna5 (AUTHOR), Wandinger-Ness, Angela5 (AUTHOR), Hudson, Laurie G.1 (AUTHOR)
Zdroj: BMC Cancer. 1/7/2021, Vol. 21 Issue 1, p1-16. 16p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje